Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19 is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
David and Lucile Packard Foundation
Grant: 2013-39274
National Science Foundation
Grant: DMS- 2028758
National Institutes of Health
Grant: R44AI138728
National Institutes of Health
Grant: UL1TR002489
National Institutes of Health
Grant: R43AI155185
National Institutes of Health
Grant: R43AI149894-01A1
National Institutes of Health
Grant: R44AI141054
NIAID NIH HHS
Grant: R21 AI090507
NIAID NIH HHS
Grant: R43 AI149894
National Institutes of Health
Grant: 1R43AI155185-01
Inhaled 'muco-trapping' antibody as universal immunotherapy for influenza virus infections
National Institutes of Health
Grant: 4R44AI141054-02
Development of RespiraClear for targeted mucosal treatment of RSV infections
National Science Foundation
Grant: 2028758
RAPID: A Lung Mucus Strategy for COVID-19 Viral Protection
National Institutes of Health
Grant: 5R44AI138728-03
In vivo dose finding for IN-002 in neonatal lambs for inhaled immunotherapy of RSV
National Institutes of Health
Grant: 1R43AI149894-01A1
Aerosol immunotherapy for treatment of human metapneumovirus infection
National Institutes of Health
Grant: 3UL1TR002489-02S1
North Carolina Translational and Clinical Science Institute (NC TraCS)
National Center for Advancing Translational Sciences
Eshelman Institute for Innovation, University of North Carolina at Chapel Hill
FWCI
0.51
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals